Johnson & Johnson has won the first-ever monopolistic dispute between a producer and dealer on the Chinese mainland, with the court rejecting the dealer’s compensation request of 14 million yuan ($2.21 million), said Shanghai No.1 Intermediate People’s Court. The US pharmaceutical company, which had cooperated with Ruibangyonghe Trading Company for 15 years, renewed its relationship with the Chinese dealer in 2008, signing a new contract regulating distribution areas and a minimum resale price for Johnson & Johnson products.
